Hereditary Testing Market Expected to Reach USD 8.9 billion by 2026
According to a new report. Key factors driving the market are declining cost of sequencing and availability of genetic tests at a lower price. Furthermore, the availability of niche and fragmented point-solutions across genomics value chain, namely sequencing, analytics, interpretation, aggregation, and marketplace, is anticipated to propel the market growth over the forecast period.
The advent of direct-to-consumer genetics is anticipated to play a major role in the genetic testing market by enabling individuals to carry out self-testing. This expands the role of genetic counselors, which further aids in understanding the importance of genetic tests and helps in the selection of appropriate tests. A growing number of registered genetic counselors is anticipated to boost the adoption of hereditary genetic tests in the coming years.
Request a Sample Copy of This Report: https://www.radiantinsights.com/research/hereditary-testing-market/request-sample
Technology developers are introducing advanced products to enhance the efficiency of genetic tests by diagnostic companies. For example, in June 2019, QIAGEN launched a new QIAseq Expanded Carrier Screening Panel, a novel Next-generation Sequencing (NGS) panel integrated with advanced bioinformatics solutions for rare and inherited diseases testing. Such ongoing developments in the market space are expected to boost revenue growth to a large extent in the coming years.
Further key findings from the report suggest:
• A substantial number of CLIA-certified laboratories perform tests to determine whether an individual carries an inherited mutated gene that can cause cancer. This has led to increased hereditary testing market share of hereditary testing for cancer in 2019
• Breast cancer testing segment has dominated the hereditary cancer testing market owing to its high penetration and increased inheritability
• On the other hand, most of the cases of cervical cancer are non-hereditary, resulting in the lowest revenue share of this segment
• Emergence of high-throughput sequencing has resulted in commercial availability of a significant number of sequencing assays for cardiomyopathies, thereby driving the cardiac diseases segment
• Non-invasive Prenatal Testing (NIPT) and newborn genetic screening continue to witness lucrative growth due to increased adoption across the globe
• Moreover, the newborn screening program has been made mandatory in several regions and countries, resulting in large share of these test types among the hereditary non-cancer testing segment
Browse Full Research Report with TOC : https://www.radiantinsights.com/research/hereditary-testing-market
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Market Scope & Segment Definition
1.4.1 Hereditary cancer testing
1.4.2 Hereditary non-cancer testing
1.4.2.1 Genetic tests
1.4.2.2 Newborn genetic screening
1.4.2.3 Preimplantation genetic diagnosis & screening
1.4.2.4 Non-invasive Prenatal Testing (NIPT) & carrier screening tests
1.5 Market Model
1.5.1 Hereditary cancer testing market
1.5.1.1 Market study
1.5.1.1.1 Price case study
1.5.1.1.2 Test provision study
1.5.1.1.3 Market competition study
1.5.1.1.4 Reimbursement study
1.5.1.2 Product mapping by cancer type & company
1.5.2 Hereditary non-cancer genetic testing market
1.5.2.1 Newborn genetic screening market
1.5.2.2 Preimplantation genetic testing market; NIPT & carrier screening market
Chapter 2 Executive Summary
2.1 Market Snapshot (2019, USD Millions)
Continued ………
Browse More Healthcare Industry Related Reports: https://www.radiantinsights.com/catalog/healthcare
About Radiant Insights, Inc.
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
201 Spear Street 1100,
Suite 3036, San Francisco,
CA 94105, United States
Tel: 1-415-349-0054
Toll Free: 1-888-928-9744
Mail: sales@radiantinsights.com
The advent of direct-to-consumer genetics is anticipated to play a major role in the genetic testing market by enabling individuals to carry out self-testing. This expands the role of genetic counselors, which further aids in understanding the importance of genetic tests and helps in the selection of appropriate tests. A growing number of registered genetic counselors is anticipated to boost the adoption of hereditary genetic tests in the coming years.
Request a Sample Copy of This Report: https://www.radiantinsights.com/research/hereditary-testing-market/request-sample
Technology developers are introducing advanced products to enhance the efficiency of genetic tests by diagnostic companies. For example, in June 2019, QIAGEN launched a new QIAseq Expanded Carrier Screening Panel, a novel Next-generation Sequencing (NGS) panel integrated with advanced bioinformatics solutions for rare and inherited diseases testing. Such ongoing developments in the market space are expected to boost revenue growth to a large extent in the coming years.
Further key findings from the report suggest:
• A substantial number of CLIA-certified laboratories perform tests to determine whether an individual carries an inherited mutated gene that can cause cancer. This has led to increased hereditary testing market share of hereditary testing for cancer in 2019
• Breast cancer testing segment has dominated the hereditary cancer testing market owing to its high penetration and increased inheritability
• On the other hand, most of the cases of cervical cancer are non-hereditary, resulting in the lowest revenue share of this segment
• Emergence of high-throughput sequencing has resulted in commercial availability of a significant number of sequencing assays for cardiomyopathies, thereby driving the cardiac diseases segment
• Non-invasive Prenatal Testing (NIPT) and newborn genetic screening continue to witness lucrative growth due to increased adoption across the globe
• Moreover, the newborn screening program has been made mandatory in several regions and countries, resulting in large share of these test types among the hereditary non-cancer testing segment
Browse Full Research Report with TOC : https://www.radiantinsights.com/research/hereditary-testing-market
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Market Scope & Segment Definition
1.4.1 Hereditary cancer testing
1.4.2 Hereditary non-cancer testing
1.4.2.1 Genetic tests
1.4.2.2 Newborn genetic screening
1.4.2.3 Preimplantation genetic diagnosis & screening
1.4.2.4 Non-invasive Prenatal Testing (NIPT) & carrier screening tests
1.5 Market Model
1.5.1 Hereditary cancer testing market
1.5.1.1 Market study
1.5.1.1.1 Price case study
1.5.1.1.2 Test provision study
1.5.1.1.3 Market competition study
1.5.1.1.4 Reimbursement study
1.5.1.2 Product mapping by cancer type & company
1.5.2 Hereditary non-cancer genetic testing market
1.5.2.1 Newborn genetic screening market
1.5.2.2 Preimplantation genetic testing market; NIPT & carrier screening market
Chapter 2 Executive Summary
2.1 Market Snapshot (2019, USD Millions)
Continued ………
Browse More Healthcare Industry Related Reports: https://www.radiantinsights.com/catalog/healthcare
About Radiant Insights, Inc.
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
201 Spear Street 1100,
Suite 3036, San Francisco,
CA 94105, United States
Tel: 1-415-349-0054
Toll Free: 1-888-928-9744
Mail: sales@radiantinsights.com
Comments
Post a Comment